Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01105780 · ClinicalTrials.gov registry record · Phase 1
JNJ-41443532 Sex, Race, and Age Pharmacokinetic (PK) Study
A Phase 1 study, sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C..
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT01105780 is a Phase 1 study that has completed, run by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.. The registered enrollment target is 32 participants.
The verdict
NCT01105780, a Phase 1 study, has completed, sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety, tolerability pharmacokinetics (how the drug is absorbed in the body, how it is distributed within the body and how it is removed from the body over time) and pharmacodynamics (the effects of the drug) of JNJ-41443532 in healthy male and female Caucasian and male Japanese participants.
Interventions
- DRUG Placebo
- DRUG JNJ-41443532
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2010-05 |
| Est. Completion | 2010-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01105780
The ClinicalTrials.gov registry entry for NCT01105780 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Pharmaceutical Research & Development, L.L.C., which has 102 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01105780 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01105780 about?
NCT01105780 is a clinical study titled "JNJ-41443532 Sex, Race, and Age Pharmacokinetic (PK) Study". The purpose of this study is to assess the safety, tolerability pharmacokinetics (how the drug is absorbed in the body, how it is distributed within the body and how it is removed from the body over time) and pharmacodynamics (the effects of the drug) of JNJ-41443532 in healthy male and female Cauca...
What is the current status of trial NCT01105780?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2010-05. Estimated completion is 2010-08.
What interventions are being tested in trial NCT01105780?
The interventions under investigation include: Placebo (DRUG), JNJ-41443532 (DRUG).
Who is sponsoring clinical trial NCT01105780?
This trial is sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C., which has 102 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.